Pathology of the Fallopian Tube: Tubal Involvement by Ovarian Tumors and Incidental Findings in the Nontumoral Setting

The fallopian tube is thought to be the site of origin of most high-grade serous carcinomas (HGSCs). However, how often the tube is abnormal in the setting of other ovarian tumors is unknown. The aim of this study is to define the frequency of tubal abnormalities in the tumoral (n = 245) and nontumoral (n = 184) setting. We found that in ovarian tumors, 52.2% of the tubes were normal, while 39.2% were affected by the tumor. Abnormal tubes were found in 80% of HGSCs, in 21% of mucinous carcinomas, in 83.3% of seromucinous carcinomas, in 33.3% of endometrioid carcinomas, in 20% of clear-cell carcinomas, and in 10.5% of borderline tumors. Among normal tubes, almost 70% were histologically normal; transitional metaplasia was present in 17.4%, endometriosis in 8.1%, and adenofibroma in 2.2%, and 1.1% had an incidental serous intraepithelial tubal carcinoma. To conclude, the fallopian tube is abnormal in most serous carcinomas, and in a smaller number of endometrioid, clear-cell and mucinous carcinomas as well as borderline tumors. It is often abnormal in seromucinous tumors, but larger series are needed to study this rare subtype.

[1]  M. Péoc'h,et al.  FOXA1 is expressed in ovarian mucinous neoplasms. , 2017, Pathology.

[2]  M. Péoc'h,et al.  Seromucinous ovarian tumor A comparison with the rest of ovarian epithelial tumors. , 2017, Annals of diagnostic pathology.

[3]  M. Péoc'h,et al.  Basic Molecular Pathology and Cytogenetics for Practicing Pathologists: Correlation With Morphology and With a Focus on Aspects of Diagnostic or Therapeutic Utility , 2016, Advances in anatomic pathology.

[4]  I. Shih,et al.  Seromucinous Tumors of the Ovary. What's in a Name? , 2016, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[5]  C. Gilks,et al.  Assessment of a new system for primary site assignment in high‐grade serous carcinoma of the fallopian tube, ovary, and peritoneum , 2015, Histopathology.

[6]  R. Pai,et al.  Lynch Syndrome Screening Should Be Considered for All Patients With Newly Diagnosed Endometrial Cancer , 2014, The American journal of surgical pathology.

[7]  W. Foulkes,et al.  The Histomorphology of Lynch Syndrome–associated Ovarian Carcinomas: Toward a Subtype-specific Screening Strategy , 2014, The American journal of surgical pathology.

[8]  B. Crawford,et al.  Early Detection of High-grade Tubal Serous Carcinoma in Women at Low Risk for Hereditary Breast and Ovarian Cancer Syndrome by Systematic Examination of Fallopian Tubes Incidentally Removed During Benign Surgery , 2014, The American journal of surgical pathology.

[9]  B. Clarke,et al.  Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation‐positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries , 2012, Cancer.

[10]  Setsuko K Chambers,et al.  Tubal origin of ovarian low-grade serous carcinoma. , 2013, American journal of clinical and experimental obstetrics and gynecology.

[11]  R. Kurman,et al.  The Fallopian Tube-Peritoneal Junction: A Potential Site of Carcinogenesis , 2011, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[12]  M. D. Post,et al.  Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin , 2011 .

[13]  C. Crum,et al.  Serous Tubal Intraepithelial Carcinoma and the Dominant Ovarian Mass: Clues to Serous Tumor Origin? , 2009, The American journal of surgical pathology.

[14]  B. Crawford,et al.  Transitional Cell Metaplasia of Fallopian Tube Fimbriae: A Potential Mimic of Early Tubal Carcinoma in Risk Reduction Salpingo-oophorectomies From Women With BRCA Mutations , 2009, The American journal of surgical pathology.

[15]  D. Bodurka,et al.  Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  K. Jensen,et al.  Microsatellite Instability and Mismatch Repair Protein Defects in Ovarian Epithelial Neoplasms in Patients 50 Years of Age and Younger , 2008, The American journal of surgical pathology.

[17]  R. Drapkin,et al.  Adenofibroma of the Fimbria: A Common Entity That Is Indistinguishable From Ovarian Adenofibroma , 2008, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[18]  B. Rosen,et al.  Occult Carcinoma in Prophylactic Oophorectomy Specimens: Prevalence and Association With BRCA Germline Mutation Status , 2001, The American journal of surgical pathology.

[19]  L. Dubeau The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? , 1999, Gynecologic oncology.

[20]  P. Russell,et al.  Transitional (urothelial) cell metaplasia of the fallopian tube mucosa: morphological assessment of three cases. , 1996, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.